posted on 2024-01-18, 05:34authored bySHUWEI LIANG
This thesis have defined the cell-autonomous and non-autonomous roles of PTPN2 in cancer immunotherapy, and have established the therapeutic potential of utilizing a small molecule inhibitor of PTPN2 to combat cancer and in particular, TNBC.